期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Advances in mesenchymal stem cells therapy for tendinopathies 被引量:1
1
作者 xu-feng mao Xi-Qian Zhang +1 位作者 Zhe-Yu Yao Hai-Jiao mao 《Chinese Journal of Traumatology》 CAS CSCD 2024年第1期11-17,共7页
Tendinopathies are chronic diseases of an unknown etiology and associated with inflammation.Mesenchymal stem cells(MSCs)have emerged as a viable therapeutic option to combat the pathological progression of tendinopath... Tendinopathies are chronic diseases of an unknown etiology and associated with inflammation.Mesenchymal stem cells(MSCs)have emerged as a viable therapeutic option to combat the pathological progression of tendinopathies,not only because of their potential for multidirectional differentiation and self-renewal,but also their excellent immunomodulatory properties.The immunomodulatory effects of MSCs are increasingly being recognized as playing a crucial role in the treatment of tendinopathies,with MSCs being pivotal in regulating the inflammatory microenvironment by modulating the immune response,ultimately contributing to improved tissue repair.This review will discuss the current knowledge regarding the application of MSCs in tendinopathy treatments through the modulation of the immune response. 展开更多
关键词 Mesenchymal stem cells TENDINOPATHY IMMUNOMODULATION TREATMENT REVIEW
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部